Ceapro Inc. (CVE:CZO – Get Free Report)’s stock price traded down 11.8% on Tuesday . The stock traded as low as C$0.23 and last traded at C$0.23. 5,850 shares were traded during trading, a decline of 88% from the average session volume of 50,562 shares. The stock had previously closed at C$0.26.
Ceapro Stock Performance
The company has a market cap of C$688,880.00, a PE ratio of -2.83 and a beta of 1.38. The company has a current ratio of 8.54, a quick ratio of 18.88 and a debt-to-equity ratio of 8.07. The firm’s 50-day simple moving average is C$0.22 and its two-hundred day simple moving average is C$0.23.
Ceapro Company Profile
Ceapro Inc, a biotechnology company, engages in the development and marketing of health and wellness products and technology relating to plant extracts in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of these technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries.
Recommended Stories
- Five stocks we like better than Ceapro
- Coke’s $10B India IPO Plan Pops the Top on Hidden Value
- FedEx Unboxes Billions in Post-Spinoff Value
- Marvell’s AI Moment Raises a Bigger Question for Amazon and ServiceNow
- Palo Alto Networks Accelerates Growth 31% on AI Demand
Receive News & Ratings for Ceapro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceapro and related companies with MarketBeat.com's FREE daily email newsletter.
